State of the Art Symposium
SA 16 - Novel therapies require novel imaging: radiologists face cellular therapies, antibodies & Co.
Lectures
1
Chairperson's introduction
05:00Michel Eisenblaetter, Detmold / DE
2
Novel cellular therapies: an overview for radiologists
15:00Lucian Beer, Vienna / AT
3
Therapy monitoring: hybrid and functional imaging
20:00Nicola Mulholland, London / UK
4
Imaging patterns of typical adverse events in CT and MRI
20:00Sandra Baleato Gonzalez, Santiago de Compostela / ES
5
Imaging patterns of typical adverse events in hybrid imaging
20:00Manil Subesinghe, London / UK
6
Panel discussion: Is hybrid imaging the solution?
10:00Panel discussion: Is hybrid imaging the solution?
This session is about the requirements diagnostic imaging has to meet in order to support novel oncologic therapies sufficiently. We will briefly cover the spectrum of novel therapeutic approaches and potentially complicating/challenging imaging and discuss the specificities for image-based therapy monitoring and imaging patterns of adverse therapy effects using CT, MRI, and hybrid imaging.
5 min
Chairperson's introduction
Michel Eisenblaetter, Detmold / Germany
15 min
Novel cellular therapies: an overview for radiologists
Lucian Beer, Vienna / Austria
20 min
Therapy monitoring: hybrid and functional imaging
Nicola Mulholland, London / United Kingdom
20 min
Imaging patterns of typical adverse events in CT and MRI
Sandra Baleato Gonzalez, Santiago de Compostela / Spain
20 min
Imaging patterns of typical adverse events in hybrid imaging
Manil Subesinghe, London / United Kingdom
10 min
Panel discussion: Is hybrid imaging the solution?